Article Details

$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData

Retrieved on: 2021-01-12 04:30:00

Tags for this article:

Click the tags to see associated articles and topics

$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData. View article details on hiswai:

Excerpt

Pfizer-BioNTech's two-shot mRNA COVID-19 vaccine, BNT-162b2, is currently the leading prophylactic vaccine for COVID-19 based on forecast sales ...

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up